Back to Results
First PageMeta Content
Cytokines / Stromal cell-derived factor-1 / Cancer research / CXC chemokine receptors / Insulin / Nanoparticle / Cell therapy / Biology / Cell biology / Nanotechnology


analysis from the makers of and
Add to Reading List

Document Date: 2014-01-26 13:16:07


Open Document

File Size: 610,28 KB

Share Result on Facebook

City

Houston / Hempstead / Basel / Geneva / Boston / Bagsvaerd / Copenhagen / Herlev / Tokyo / Barcelona / Chengdu / London / New Haven / Toronto / Villejuif / Mountain View / Liverpool / Cambridge / Frankfurt / Abingdon / Taipei / Paris / Manchester / Watertown / Amsterdam / Nottingham / New York / La Jolla / San Diego / /

Company

CXCR7 / Blend Therapeutics Inc. / Novo Nordisk A/S / Companies Institutions Microvitae Technologies / Netherlands Nuevolution A/S / Canada Sitari Pharmaceuticals Corp. / Dainippon Sumitomo Pharma Co. Ltd. / Sanofi / Janssen Labs / Singapore Sanofi / BioSpring GmbH / Md. Novartis AG / Toxicology GmbH & Co. KG / Agency for Science / Avalon Ventures / Eric Pierce Marketing / HitGen Ltd. / COMPANIES AND INSTITUTIONS MENTIONED Avalon Ventures / TCM Biotech International Corp. / Dr. Reddy’s Laboratories Ltd. / CXCR4 / arGEN-X B.V. / Johnson & Johnson / Undisclosed Partnership / J&J Corporate Office / Midatech Ltd. / FGFR1-CXCR4 ChemoCentryx Inc. / Evotec AG / GlaxoSmithKline plc / Nature Publishing Group / DBV Technologies / ImmunoGenes AG / AstraZeneca plc / MaRS Innovation Pharmaceuticals / Purpose Prosensa Holding N.V. / IgG / Summit Corp. plc / U.K. GlaxoSmithKline plc / France HitGen Ltd. / Emisphere Technologies Inc. / BioCentury Publications Inc. / Discovery Partnerships / Malaria Venture / Angiocrine Bioscience Inc. / China Johnson & Johnson / BioNet-Asia Co. Ltd. / Joint / Sitari Pharmaceuticals Corp. / CXCR7-ID1 / Cancer Research UK Cancer Undisclosed Partnership / Japan BCG Laboratory Ltd. / INDEXES 23 Company / Redx Pharma Ltd. / Altus Biologics Inc. / Denmark Novartis AG / Immunology Diagnostics / InteRNA Technologies B.V. / Nordic Bioscience A/S / DMD ApoCell Inc. / Cancer Research UK / Cancer Research Technology Ltd. / Leukemia & Lymphoma Society Cancer Undisclosed Partnership / Althea Technologies Inc. / Quiet Therapeutics Ltd. / Sigma-Tau Group / Denmark Selecta Biosciences Inc. / Novartis AG / Bind Therapeutics Inc. / Nuevolution A/S / Selecta Biosciences Inc. / ChemoCentryx Inc. / U.K. Cancer Research UK / Switzerland Novo Nordisk A/S / Chiyoda / /

Country

Finland / France / Canada / United States / United Kingdom / Taiwan / Singapore / /

Currency

USD / EUR / GBP / CAD / /

/

Event

FDA Phase / Business Partnership / Company Expansion / M&A / Patent Filing / Bankruptcy / /

Facility

Howard Hughes Medical Institute / University of Eastern Finland / Scito S.A. Institute of Myology / COMPANIES AND INSTITUTIONS MENTIONED Genomics Institute / University of California / The David H. Koch Institute / the Netherlands Cancer Institute / B.V. Neurology Academic Medical Center / ModiQuest Research B.V. Beckman Research Institute / Mario Negri Institute / Md. Netherlands Cancer Institute / Calif. Hofstra University / That facility / Medical Institute / Canada Memorial Sloan-Kettering Cancer Center / Novartis Institute / Germany Massachusetts Institute of Technology / Massachusetts Institute of Technology / Co. KG VU University Medical Center / University Hospital Bonn / David H. Koch Institute / Imperial College / Switzerland National Institute of Allergy / Aix-Marseille University / University of Veterinary Medicine / The University of Texas MD Anderson Cancer Center / Switzerland Novartis Institute / University of Nottingham / D outpost / GSK pipeline / Catholic University / University of Ferrara / DMD ApoCell Inc. Fraunhofer Institute / U.K. MIT-Harvard Center of Cancer Nanotechnology Excellence / Laboratory of Pharmacology / National Institute / Ben-Gurion University / The University of Manchester Cancer Undisclosed Partnership / Lund University / AmorChem L.P. Center University Hospital of Quebec / Texas Vall d’Hebron Institute of Oncology / University College London / University of Oxford / Brown University / The University of Manchester / N.J. Goethe University / University of Oxford Neurology Undisclosed Partnership / Musculoskeletal Leiden University Medical Center / Weill Cornell Medical College / London The Macmillan Building / Gustave Roussy Institute / Denmark Princess Margaret Cancer Centre / Memorial Sloan-Kettering Cancer Center / Italy University of California / Vall d’Hebron Institute of Oncology / Nencki Institute of Experimental Biology / The University of Nottingham / Women’s Hospital / U.K. Gustave Roussy Institute / NIH’s National Institute / /

Holiday

Thanksgiving / /

IndustryTerm

booster vaccine / pharma kinase catalytic site / vector technology / early stage life science technologies / mucosal tuberculosis / immunological applications / cell selection technology / pharmaceutical chemistry / nanoparticle technology / life sciences technologies / /

MarketIndex

HOLIDAY / /

MedicalCondition

Leukemia / tumor / acute liver injury / endometriosis / Allergy / infection / fibrosis CXCR7 / only prevented fibrosis / society’s screen-to-lead cancer / mucosal tuberculosis / head cancers / dormant Plasmodium infection / Musculoskeletal disease / cancer / effects liver injury / fibrosis / N.Y. liver fibrosis / scar / multiple myeloma functions / rare neuromuscular diseases / pertussis / autism / Infectious Diseases / liver injury / exocrine pancreatic insufficiency / injury / multiple sclerosis / hematological diseases / diabetes / osteoporosis / neck cancers / epilepsy / deficiency / pulmonary indications / lymphoma / solid tumors / inflammatory molecules / dependent cancers / disease / osteoarthritis / acute and chronic liver injury / brain cancer / Tropical Diseases / thrombosis / ophthalmic disorders / celiac disease / human parainfluenza type / cardiovascular diseases / Chronic liver injury / undisclosed new cancer / malaria / initial infection / malarial disease / muscular dystrophy / hematological malignancies / N.Y. and inflammatory factors / GlaxoSmithKline plc’s malaria / obesity / cystic fibrosis / undisclosed cancer / human epithelial colorectal adenocarcinoma cell monolayer / Disclosed value Companies Institutions Business area ImmunoGenes AG Public Health England Infectious disease / liver fibrosis / Inflammation / /

MedicalTreatment

immunotherapy / organ transplant / /

MusicGroup

ALL RIGHTS RESERVED / /

NaturalFeature

Negev / West Coast / /

OperatingSystem

Aix / /

Organization

Genomics Institute / AmorChem L.P. Center University Hospital of Quebec / UCSD / B.V. Neurology Academic Medical Center / Lund University / Harvard Medical School / NIH’s National Institute / University of Oxford Neurology Undisclosed Partnership / Yale School of Medicine / Vall d’Hebron Institute of Oncology / Medical Research Council / Ben-Gurion University of the Negev / Harvard Center of Cancer Nanotechnology Excellence / San Francisco PO / David H. Koch Institute for Integrative Cancer Research / ModiQuest Research B.V. Beckman Research Institute of the City of Hope Antibodies Undisclosed Collaboration / Nature Publishing Group Joint Steering Committee / Hofstra University / European Commission / University of Manchester / European Union / NHS / University of Texas / Catholic University of the Sacred Heart / National Institute / Center for Biomedical Engineering / Imperial College London / Hannover Medical School / Women’s Hospital / University of Manchester Cancer Undisclosed Partnership / NIH’s National Center for Advancing Translational Sciences / University of Veterinary Medicine / Vienna / Aix-Marseille University / Laboratory of Pharmacology / Howard Hughes Medical Institute / Laval University / Nencki Institute of Experimental Biology / Switzerland National Institute of Allergy and Infectious Diseases / University of Geneva Infectious / Princess Margaret Cancer Centre / Massachusetts Institute of Technology / University of Oxford / Medical Institute / Scito S.A. Institute of Myology / US Federal Reserve / Center for Excellence for External Drug Discovery / Gustave Roussy Institute / University College London / Brown University / Novartis Institute / the Netherlands Cancer Institute / Institute for Tropical Diseases in Singapore / DMD ApoCell Inc. Fraunhofer Institute for Cell Therapy / Weill Cornell Medical College / Novartis Institute for Tropical Diseases / Agency for Science / Technology and Research / N.J. Goethe University Frankfurt / Musculoskeletal Leiden University Medical Center / University of Ferrara / N.Y. National Center for Advancing Translational Sciences / University of California / San Diego / OTCT / Cornell / Mario Negri Institute for Pharmacological Research / Immuno-Oncology and Combinations Discovery Performance Unit / Novartis Research Foundation / University of Nottingham / Memorial Sloan-Kettering Cancer Center / Netherlands Cancer Institute / /

Person

C. Simone Fishburn / Nat / Louis Miller / Edith Mathiowitz / Tracey Baas / Chris Cain / Lev Osherovich / Kai-Jye Lou / Elizabeth Winzeler / Steve Edelson / Jim Chen / Michael J. Haas / Shahin Rafii / David Flores / Carol Evangelista / Jörg Kreuter / Timothy Wells / Omid Farokhzad / Benjamin Boettner / Amy Donner / Peter Collins / N.Y. Rafii / Ron Rabinowitz / Anthony Barrera / Chevy Chase / Thierry Diagana / Brandy Cafarella / Gaspar Taroncher-Oldenburg / Sara Girard / Karen Bernstein / Ivelisse Robles / Kevin Lehnbeuter / Gamo Benito / Christoph Hesselmann / Damien McDevitt / Lauren Martz / Jeff Hrkach / Walter Yang / Francisco Javier Gamo Benito / Inchcoombe / Bi-Sen Ding / Julia Kulikova / Thomas Rademacher / Elizabeth A. Winzeler / Axel Hoos / Tim Tulloch / Omid C. Farokhzad / Claudia Bentley / Mark Zipkin / Miles Davies / Dean Sanderson / /

/

Position

Managing Director / Chairman & Editor-in-Chief / Managing Editor / professor of anesthesia / investigator / co-investigator / VP of business development and site head / professor of genetic medicine / Chief Financial Officer / director of translational research / professor of pharmaceutical chemistry / Director / Writer / chief / professor of pediatrics / Research Manager / Director / Finance / Editor / Executive Editor / Editor-in-Chief / professor of genetic and regenerative medicine / first author / head / SVP of technology and R&D / Staff Writer / professor of medical science / associate professor / Editorial Assistant / VP / director of the Biotechnology Graduate Program and a member / project manager / President & CEO / VP of business development and site head of West Coast R&D satellite / /

Product

glucagon / primaquine / TCM-808FB / Accurins / polyethylene glycol / Building 6F 2-37 Ichigayatamachi Shinjuku / SciBX / Eligen oral drug delivery platform / Malarone / Eligen / GSK257049 / FGFR1 / GSK932121 / Undisclosed drug / /

ProgrammingLanguage

Cedar / DC / /

ProvinceOrState

New Brunswick / South Carolina / Ontario / Connecticut / Maryland / Quebec / California / Texas / Massachusetts / New York / Rhode Island / /

Region

Eastern Finland / West Coast / /

SportsEvent

NHL / /

Technology

siRNA / Chemetics technology / Business Intelligence / 2 vector technology / Antibodies / Biotechnology / cell signaling / cell selection technology / nanoparticle technology / DNA binding / drug delivery / Drug Discovery / Spectroscopy / FCRN-binding technology / Cell Therapy / to-BBB technologies / Toronto-based life sciences technologies / Genomics / Greg Monteforte Technology / early stage life science technologies / FCRN technology / drug development / regenerative medicine / /

SocialTag